RT Journal Article
SR Electronic
T1 The Impact of COVID-19 on Medical Practice: A Nationwide Survey of Dermatologists and Healthcare Providers in Iraq
JF medRxiv
FD Cold Spring Harbor Laboratory Press
SP 2020.07.26.20156380
DO 10.1101/2020.07.26.20156380
A1 Shanshal, Mohammed
A1 Ahmed, Hayder Saad
A1 Asfoor, Hayder
A1 Salih, Raad Ibrahim
A1 Ali, Shehab Ahmed
A1 Aldabouni, Yusif k.
YR 2020
UL http://medrxiv.org/content/early/2020/11/28/2020.07.26.20156380.abstract
AB The COVID-19 pandemic has dramatically changed medical practice worldwide. It posed a significant impact on different health services, including dermatology. A Cross-sectional observational study of 200 healthcare providers and 100 dermatologists (survey 1 and 2, respectively) were conducted to determine the prevalence of occupational skin diseases among healthcare providers working amid the pandemic, and to demonstrate the outbreak’s impact on dermatology practice.Most healthcare providers (83%) reported hygiene-related hand dermatitis. The rates of PPE- related dermatoses were estimated to be 73%, including pressure injuries (51.9%), acne (33.1%), non-gloves contact dermatitis (29.9%), nonspecific eruption (17.5%), urticaria (9.1%) and skin infections (3.2%). The emerging COVID-19-related cutaneous manifestations were recognized by 20% of surveyed dermatologists, including maculopapular eruption (41.67%), urticaria (37.50%), chilblain (25%) and vasculitis (16.67). Telemedicine was provided by 73% of the dermatologists, and 89% reported minimal use of immunosuppressive drugs amid the pandemic.Competing Interest StatementThe authors have declared no competing interest.Clinical TrialNon applicableFunding StatementFunding sources: NoneAuthor DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:Arab Board of Health Specialization, MOH IraqAll necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesThe used surveys are available for readers. https://drive.google.com/drive/folders/1eH6inpIkkWpkJVmHYVNqmxXaBXQo9bJN?usp=sharing